Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
research is MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR-based technology that enables precise engineering of thousands of defined mutations in parallel, in a single test tube. By linking each
-
numerical modelling, wave-flume experiments and field measurements. The project offers a unique opportunity for a PhD candidate to develop computational and experimental expertise, build a professional
-
neuroinflammatory diseases. Drawing on parallels with the retroviral replication cycle, we identified host factors involved in LINE-1 transposition. This PhD project builds upon that work. Specifically, we
-
including simulations of FUS biophysics and validation in experimental in-vitro/in-vivo setups. The first subobjective is to build extensive validated knowledge of the biophysics of FUS for vagus nerve
-
Location: Leuven ABOUT THE ROLE VIB is home to world-class science and international talent. In this environment, strong HR expertise goes hand in hand with understanding complexity, building
-
with research, practice or capacity-building related to equity and inclusion. You have an established research career with a strong record of scientific dissemination, peer-review processes and
-
000 employees from 100 different countries, we are helping to build tomorrow's world every day. Through top scientific research, we push back boundaries and set a course for the future – a future that
-
. The project offers a unique opportunity for a PhD candidate to develop computational and experimental expertise, build a professional network with research and industry partners, and contribute
-
interest or stronger experience in one of these areas, we would be very interested to hear about it. Your work will involve developing, adapting and fine-tuning computational pipelines, often building
-
collaborative mindset that will allow you to build bridges between existing research groups at VIB and KU Leuven, as well as with other academic centers and the industry. You will focus on novel omics